PL3511015T3 - Genetycznie stabilna żywa atenuowana szczepionka przeciw syncytialnemu wirusowi oddechowemu i jej wytwarzanie - Google Patents

Genetycznie stabilna żywa atenuowana szczepionka przeciw syncytialnemu wirusowi oddechowemu i jej wytwarzanie

Info

Publication number
PL3511015T3
PL3511015T3 PL19150800T PL19150800T PL3511015T3 PL 3511015 T3 PL3511015 T3 PL 3511015T3 PL 19150800 T PL19150800 T PL 19150800T PL 19150800 T PL19150800 T PL 19150800T PL 3511015 T3 PL3511015 T3 PL 3511015T3
Authority
PL
Poland
Prior art keywords
production
respiratory syncytial
syncytial virus
live attenuated
virus vaccine
Prior art date
Application number
PL19150800T
Other languages
English (en)
Inventor
Peter L. Collins
Cindy L. Luongo
Ursula J. Buchholz
Brian R. Murphy
Original Assignee
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The United States Of America, As Represented By The Secretary, Department Of Health And Human Services filed Critical The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
Publication of PL3511015T3 publication Critical patent/PL3511015T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18521—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18561—Methods of inactivation or attenuation
    • C12N2760/18562—Methods of inactivation or attenuation by genetic engineering

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL19150800T 2012-04-13 2013-03-13 Genetycznie stabilna żywa atenuowana szczepionka przeciw syncytialnemu wirusowi oddechowemu i jej wytwarzanie PL3511015T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261624010P 2012-04-13 2012-04-13
PCT/US2013/030836 WO2013154728A1 (en) 2012-04-13 2013-03-13 Genetically stable live attenuated respiratory syncytial virus vaccine and its production
EP13712641.3A EP2836231B1 (en) 2012-04-13 2013-03-13 Genetically stable live attenuated respiratory syncytial virus vaccine and its production
EP19150800.1A EP3511015B1 (en) 2012-04-13 2013-03-13 Genetically stable live attenuated respiratory syncytial virus vaccine and its production

Publications (1)

Publication Number Publication Date
PL3511015T3 true PL3511015T3 (pl) 2021-09-13

Family

ID=47998536

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19150800T PL3511015T3 (pl) 2012-04-13 2013-03-13 Genetycznie stabilna żywa atenuowana szczepionka przeciw syncytialnemu wirusowi oddechowemu i jej wytwarzanie

Country Status (7)

Country Link
US (4) US9624475B2 (pl)
EP (3) EP3875112A1 (pl)
DK (1) DK3511015T3 (pl)
ES (1) ES2863477T3 (pl)
PL (1) PL3511015T3 (pl)
PT (1) PT3511015T (pl)
WO (1) WO2013154728A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3875112A1 (en) * 2012-04-13 2021-09-08 The United States of America, as Represented By the Secretary, Department of Health and Human Services Genetically stable live attenuated respiratory syncytial virus vaccine and its production
WO2017030997A1 (en) * 2015-08-14 2017-02-23 Research Institute At Nationwide Children's Hospital Respiratory syncytial virus having altered ns1 protein function and related materials and methods
CA3007408A1 (en) * 2015-12-11 2017-06-15 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Recombinant respiratory syncytial virus strains with mutations in the m2-2 orf providing a range of attenuation phenotypes
WO2023154960A1 (en) 2022-02-14 2023-08-17 University Of Georgia Research Foundation, Inc. Pan-pneumovirus vaccine compositions and methods of use thereof
CN114574521B (zh) * 2022-03-03 2023-09-12 山东中医药大学 一种基于平衡补偿的重组流感病毒构建方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3224404A1 (de) 1982-06-30 1984-01-05 LuK Lamellen und Kupplungsbau GmbH, 7580 Bühl Reibungskupplung sowie verfahren zu deren montage
IL105456A (en) * 1992-04-21 1996-12-05 American Home Prod Vaccines of attenuated respiratory syncytial virus
US6713066B1 (en) * 1996-07-15 2004-03-30 The United States Of America As Represented By The Department Of Health And Human Services Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2
US7846455B2 (en) * 1996-07-15 2010-12-07 The United States Of America As Represented By The Department Of Health And Human Services Attenuated chimeric respiratory syncytial virus
EP2112220A3 (en) * 1996-07-15 2010-01-06 The Government of the United States of America, as represented by The Department of Health and Human Services Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
EP1287152B1 (en) * 1999-07-09 2008-12-31 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, represented by THE DEPARTMENT OF HEALTH & HUMAN SERVICES Human-bovine chimeric respiratory syncytial virus vaccines
EP3875112A1 (en) * 2012-04-13 2021-09-08 The United States of America, as Represented By the Secretary, Department of Health and Human Services Genetically stable live attenuated respiratory syncytial virus vaccine and its production

Also Published As

Publication number Publication date
EP3511015B1 (en) 2020-12-30
DK3511015T3 (da) 2021-03-15
US10307476B2 (en) 2019-06-04
WO2013154728A1 (en) 2013-10-17
US20150118732A1 (en) 2015-04-30
EP3511015A1 (en) 2019-07-17
US20170189520A1 (en) 2017-07-06
ES2863477T3 (es) 2021-10-11
US20210330782A1 (en) 2021-10-28
EP3875112A1 (en) 2021-09-08
PT3511015T (pt) 2021-04-05
US20190282690A1 (en) 2019-09-19
EP2836231A1 (en) 2015-02-18
US10980872B2 (en) 2021-04-20
US9624475B2 (en) 2017-04-18
EP2836231B1 (en) 2019-01-09

Similar Documents

Publication Publication Date Title
IL261204A (en) Influenza virus vaccines and their use
IL262123A (en) Influenza virus vaccines and their uses
HK1199211A1 (en) Influenza virus vaccines and uses thereof
SG11201510746WA (en) Respiratory syncytial virus (rsv) vaccine
HK1209646A1 (en) Nasal influenza vaccine composition
HK1209157A1 (en) Extraction, preparation, and application of plant micro-ribonucleic acid
IL240504A0 (en) Combined vaccine for respiratory syncytial virus and influenza
PT2806891T (pt) Vacinas baseadas no vírus parainfluenza 5
IL222723A0 (en) Respiratory syncytial virus antigenic compositions and methods
EP2940134A4 (en) USING THE HUMAN PARAIN FLUENZAVIRUS TYPE 2 VEGETABLE VACCINE
EP3022298A4 (en) WAXED INFLUENZA VACCINE AND USES THEREOF
PL2969005T3 (pl) Atenuowane wirusy grypy i szczepionki
HK1223644A1 (zh) 呼吸道合胞病毒半活疫苗
PT3511015T (pt) Vacina viva e atenuada e geneticamente estável contra o vírus sincicial respiratório e a sua produção
HK1223643A1 (zh) 呼吸道合胞病毒半活疫苗
EP2870238A4 (en) COMPOSITIONS AND METHODS ASSOCIATED WITH VIRAL VACCINES
EP2884998A4 (en) ATTENUATED LIVE VACCINE AGAINST THE KRIM-KONGO-HEMORRHAGIC FEVER AND ERVE VIRUS
PL2855513T3 (pl) Szczepionka przeciwko wirusowi Schmallenberg (SBV), sposoby wytwarzania i jej zastosowanie
HK1201283A1 (en) Influenza c virus and vaccine
ZA201405107B (en) Mtb-c vaccine against asthma
HK1213949A1 (zh) 活疫苗製備
EP2777712A4 (en) AUXILIARY SUBSTANCES FOR POLYSACCHARIDIVES AND FORMULATIONS OBTAINED THEREFROM